Sharps Technology, Inc. (STSS)

0.2328 -0.0184 (-7.32%) At close: 04:00PM EDT

Sharps Technology, Inc.

105 Maxess Road
Suite 124
Melville, NY 11747
United States
631-574-4436
https://sharpstechnology.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 57

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert M. Hayes	CEO & Director	516.67k	N/A	1968
Mr. Andrew R. Crescenzo CPA	Chief Financial Officer	236.23k	N/A	1956
Mr. Ben Scheu	Senior Director of Sales	N/A	N/A	N/A
Dr. Steven Hertz M.D.	Chief Medical Officer	N/A	N/A	1962
Mr. Adam S. Holdsworth	Managing Director	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

Corporate Governance

Sharps Technology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.